{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:33:28Z","timestamp":1793795608537,"version":"4.6.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LO 274\/15-"],"award-info":[{"award-number":["LO 274\/15-"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"ERC","doi-asserted-by":"publisher","award":["2013-AdG 341116"],"award-info":[{"award-number":["2013-AdG 341116"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008392","name":"Danish Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.neuropharm.2018.09.025","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T19:55:23Z","timestamp":1537559723000},"page":"186-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy"],"prefix":"10.1016","volume":"143","author":[{"given":"Claudia","family":"Brandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Seja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"T\u00f6llner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"R\u00f6mermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kalesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andi","family":"Kipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Feit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Lykke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine Lisberg","family":"Toft-Bertelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauliina","family":"Paavilainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inkeri","family":"Spoljaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Puskarjov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna","family":"MacAulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kaila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.09.025_bib1","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s11064-015-1519-z","article-title":"Regulation and function of AQP4 in the central nervous system","volume":"40","author":"Assentoft","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib1a","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-94-017-8914-1_23","article-title":"What new modeling approaches will help us identify promising drug treatments?","volume":"813","author":"Baraban","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1113\/jphysiol.1989.sp017762","article-title":"Giant synaptic potentials in immature rat CA3 hippocampal neurones","volume":"416","author":"Ben Ari","year":"1989","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1073858412438697","article-title":"The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders","volume":"18","author":"Ben Ari","year":"2012","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fncel.2016.00090","article-title":"Failure of the nemo trial: bumetanide is a promising agent to treat many brain disorders but not newborn seizures","volume":"10","author":"Ben Ari","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1124\/dmd.109.029629","article-title":"Prediction of V(ss) from in vitro tissue-binding studies","volume":"38","author":"Berry","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/glia.22317","article-title":"Aquaporin-4 and epilepsy","volume":"60","author":"Binder","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2009.03.003","article-title":"Cation-chloride cotransporters and neuronal function","volume":"61","author":"Blaesse","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1528-1167.2008.01797.x","article-title":"Assessment of seizure susceptibility in pilocarpine epileptic and nonepileptic Wistar rats and of seizure reinduction with pentylenetetrazole and electroshock models","volume":"50","author":"Blanco","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib9","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1523\/JNEUROSCI.0633-10.2010","article-title":"Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy","volume":"30","author":"Brandt","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib10","first-page":"53","article-title":"Regulation of the Na-K-Cl cotransporter in the intact rectal gland of the spiny dogfish, Sqalus acanthias","volume":"34","author":"Brill","year":"1995","journal-title":"Bulletin of Mt. Desert Island Biological Laboratory"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib11","doi-asserted-by":"crossref","first-page":"e57148","DOI":"10.1371\/journal.pone.0057148","article-title":"Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures","volume":"8","author":"Cleary","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib12","doi-asserted-by":"crossref","first-page":"a022434","DOI":"10.1101\/cshperspect.a022434","article-title":"Role of astrocytes in epilepsy","volume":"5","author":"Coulter","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib2a","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneumeth.2008.04.019","article-title":"The pilocarpine model of temporal lobe epilepsy","volume":"172","author":"Curia","year":"2008","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2017.11.002","article-title":"KCC2, epileptiform synchronization, and epileptic disorders","volume":"162","author":"Di Cristo","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nm1301","article-title":"NKCC1 transporter facilitates seizures in the developing brain","volume":"11","author":"Dzhala","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.21229","article-title":"Bumetanide enhances phenobarbital efficacy in a neonatal seizure model","volume":"63","author":"Dzhala","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/epi.13346","article-title":"The bumetanide prodrug BUM5, but not bumetanide, potentiates the antiseizure effect of phenobarbital in adult epileptic mice","volume":"57","author":"Erker","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib17","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1124\/mol.116.103929","article-title":"Experimental evaluation of proposed small-molecule inhibitors of water channel Aquaporin-1","volume":"89","author":"Esteva-Font","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Meth."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00018-009-0218-9","article-title":"Differential water permeability and regulation of three aquaporin 4 isoforms","volume":"67","author":"Fenton","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2007.06.021","article-title":"Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice","volume":"207","author":"Gr\u00f6ticke","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib21","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/jps.2600730821","article-title":"Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects","volume":"73","author":"Holazo","year":"1984","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainresbull.2017.02.011","article-title":"The role of aquaporin-4 in synaptic plasticity, memory and disease","volume":"136","author":"Hubbard","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bmc.2007.12.038","article-title":"Inhibition of aquaporin 4 by antiepileptic drugs","volume":"17","author":"Huber","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.mam.2012.01.002","article-title":"Aquaporins in drug discovery and pharmacotherapy","volume":"33","author":"Huber","year":"2012","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib25","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1523\/JNEUROSCI.2761-07.2007","article-title":"Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy","volume":"27","author":"Huberfeld","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib26","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1471-4159.1993.tb13648.x","article-title":"Ionic composition of cisternal CSF in acute respiratory acidosis: lack of effect of large dose bumetanide","volume":"61","author":"Javaheri","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrn3819","article-title":"Cation-chloride cotransporters in neuronal development, plasticity and disease","volume":"15","author":"Kaila","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.conb.2013.11.004","article-title":"GABA actions and ionic plasticity in epilepsy","volume":"26","author":"Kaila","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/bdd.325","article-title":"Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery","volume":"23","author":"Kalvass","year":"2002","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fncel.2015.00173","article-title":"Age- and sex-dependent susceptibility to phenobarbital-resistant neonatal seizures: role of chloride co-transporters","volume":"9","author":"Kang","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib31","series-title":"Commonalities in Epileptogenic Processes from Different Acute Brain Insults: Do They Translate?","author":"Klein","year":"2018"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib32","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.eplepsyres.2014.10.002","article-title":"Low doses of ethanol markedly potentiate the anticonvulsant effect of diazepam in a mouse model of difficult-to-treat focal seizures","volume":"108","author":"Klein","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.24870","article-title":"Depolarizing gamma-aminobutyric acid contributes to glutamatergic network rewiring in epilepsy","volume":"81","author":"Kourdougli","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.nbd.2009.12.002","article-title":"Kindling as a model of temporal lobe epilepsy induces bilateral changes in spontaneous striatal activity","volume":"37","author":"K\u00fccker","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib36","doi-asserted-by":"crossref","first-page":"e1056","DOI":"10.1038\/tp.2017.10","article-title":"Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders","volume":"7","author":"Lemonnier","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2008.04.047","article-title":"Long-term expressional changes of Na+ -K+ -Cl- co-transporter 1 (NKCC1) and K+ -Cl- co-transporter 2 (KCC2) in CA1 region of hippocampus following lithium-pilocarpine induced status epilepticus (PISE)","volume":"1221","author":"Li","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jchromb.2011.02.018","article-title":"Sensitive isotope dilution liquid chromatography\/tandem mass spectrometry method for quantitative analysis of bumetanide in serum and brain tissue","volume":"879","author":"Li","year":"2011","journal-title":"J Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/pr.2012.7","article-title":"Bumetanide augments the neuroprotective efficacy of phenobarbital plus hypothermia in a neonatal hypoxia-ischemia model","volume":"71","author":"Liu","year":"2012","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib3a","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0301-0082(97)00035-X","article-title":"Animal models of intractable epilepsy","volume":"53","author":"L\u00f6scher","year":"1997","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib4a","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1528-1157.1998.tb01304.x","article-title":"Selection of phenytoin responders and nonresponders in male and female amygdala-kindled Sprague-Dawley rats","volume":"39","author":"L\u00f6scher","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0920-1211(93)90058-F","article-title":"Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy","volume":"15","author":"L\u00f6scher","year":"1993","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"L\u00f6scher","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuropharm.2012.05.045","article-title":"Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments","volume":"69","author":"L\u00f6scher","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eplepsyres.2016.05.016","article-title":"Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies","volume":"126","author":"L\u00f6scher","year":"2016","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib45","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1111\/bph.13231","article-title":"Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of human NKCC2 variant A","volume":"172","author":"Lykke","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yebeh.2016.03.021","article-title":"The search for NKCC1-selective drugs for the treatment of epilepsy: structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A","volume":"59","author":"Lykke","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib47","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1528-1167.2011.03203.x","article-title":"Diuretics and epilepsy: will the past and present meet?","volume":"52","author":"Maa","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00424-013-1370-5","article-title":"Physiology and pathophysiology of SLC12A1\/2 transporters","volume":"466","author":"Markadieu","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fncel.2014.00027","article-title":"Current view on the functional regulation of the neuronal K(+)-Cl(-) cotransporter KCC2","volume":"8","author":"Medina","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/mol.108.053744","article-title":"Inhibition of aquaporin-1 and aquaporin-4 water permeability by a derivative of the loop diuretic bumetanide acting at an internal pore-occluding binding site","volume":"76","author":"Migliati","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib51","series-title":"JASPER'S BASIC MECHANISMS of the EPILEPSIES","first-page":"581","article-title":"Chloride homeostasis and GABA signaling in temporal lobe epilepsy","author":"Miles","year":"2012"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/bk-1978-0083.ch002","article-title":"Structure-activity relationships of aminobenzoic acid diuretics and related compounds","volume":"83","author":"Nielsen","year":"1978","journal-title":"Am. Chem. Soc. Symp. Ser. , Diuretic Agents"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0168-0102(02)00093-7","article-title":"Amygdala kindling induces upregulation of mRNA for NKCC1, a Na(+), K(+)-2Cl(-) cotransporter, in the rat piriform cortex","volume":"44","author":"Okabe","year":"2002","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(03)03528-5","article-title":"Changes in chloride homeostasis-regulating gene expressions in the rat hippocampus following amygdala kindling","volume":"990","author":"Okabe","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0773.1977.tb03209.x","article-title":"The pharmacology of bumetanide","volume":"41","author":"Olsen","year":"1977","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib56","first-page":"11","article-title":"A metal complexing property of furosemide and bumetanide: determination of pK and stability constant","volume":"26","author":"Orita","year":"1976","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib57","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on therapeutic strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","article-title":"Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial","volume":"14","author":"Pressler","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib59","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/epi.12620","article-title":"Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures","volume":"55","author":"Puskarjov","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib60","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/cbdv.200900103","article-title":"Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept","volume":"6","author":"Reichel","year":"2009","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib61","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.02.006","article-title":"Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain","volume":"117","author":"R\u00f6mermann","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1152\/physrev.2000.80.1.211","article-title":"Sodium-potassium-chloride cotransport","volume":"80","author":"Russell","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib63","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.addr.2004.07.011","article-title":"Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics","volume":"56","author":"Shen","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib64","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1523\/JNEUROSCI.0378-05.2005","article-title":"Depolarizing GABA acts on intrinsically bursting pyramidal neurons to drive giant depolarizing potentials in the immature hippocampus","volume":"25","author":"Sipil\u00e4","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib65","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1460-9568.2006.04757.x","article-title":"Intrinsic bursting of immature CA3 pyramidal neurons and consequent giant depolarizing potentials are driven by a persistent Na+ current and terminated by a slow Ca2+ -activated K+ current","volume":"23","author":"Sipil\u00e4","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib66","doi-asserted-by":"crossref","first-page":"C426","DOI":"10.1152\/ajpcell.00298.2003","article-title":"Sevenfold-reduced osmotic water permeability in primary astrocyte cultures from AQP-4-deficient mice, measured by a fluorescence quenching method","volume":"286","author":"Solenov","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib67","doi-asserted-by":"crossref","first-page":"17308","DOI":"10.1074\/jbc.M112.356014","article-title":"Loop diuretic and ion-binding residues revealed by scanning mutagenesis of transmembrane helix 3 (TM3) of Na-K-Cl cotransporter (NKCC1)","volume":"287","author":"Somasekharan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib68","doi-asserted-by":"crossref","first-page":"E10819","DOI":"10.1073\/pnas.1717337114","article-title":"Vasopressin excites interneurons to suppress hippocampal network activity across a broad span of brain maturity at birth","volume":"114","author":"Spoljaric","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib69","doi-asserted-by":"crossref","first-page":"16423","DOI":"10.1523\/JNEUROSCI.2506-11.2011","article-title":"The anticonvulsant response to valproate in kindled rats is correlated with its effect on neuronal firing in the substantia nigra pars reticulata: a new mechanism of pharmacoresistance","volume":"31","author":"T\u00f6llner","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib70","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.24124","article-title":"A novel prodrug-based strategy to increase effects of bumetanide in epilepsy","volume":"75","author":"T\u00f6llner","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib71","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/ejn.12424","article-title":"Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy","volume":"39","author":"T\u00f6pfer","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib5a","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/abio.2001.5398","article-title":"Quantitation of Na+-K+-2Cl- cotransport splice variants in human tissues using kinetic polymerase chain reaction","volume":"298","author":"Vibat","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2014.11.031","article-title":"In vivo effects of bumetanide at brain concentrations incompatible with NKCC1 inhibition on newborn DGC structure and spontaneous EEG seizures following hypoxia-induced neonatal seizures","volume":"286","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.09.025_bib73","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fncel.2015.00371","article-title":"Development and regulation of chloride homeostasis in the central nervous system","volume":"9","author":"Watanabe","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib74","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1002\/jps.21317","article-title":"Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding","volume":"97","author":"Waters","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib75","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1113\/jphysiol.2004.062471","article-title":"Cl- uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1","volume":"557","author":"Yamada","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib77","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1113\/jphysiol.2005.100933","article-title":"Water transport by Na+-coupled cotransporters of glucose (SGLT1) and of iodide (NIS). The dependence of substrate size studied at high resolution","volume":"570","author":"Zeuthen","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.09.025_bib78","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1113\/jphysiol.2011.226316","article-title":"Cotransport of water by Na(+)-K(+)-2Cl(-) cotransporters expressed in Xenopus oocytes: NKCC1 versus NKCC2","volume":"590","author":"Zeuthen","year":"2012","journal-title":"J. Physiol."}],"updated-by":[{"DOI":"10.1016\/j.neuropharm.2018.10.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000}}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T01:36:08Z","timestamp":1543282568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818306774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":81,"alternative-id":["S0028390818306774"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.025","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.neuropharm.2018.10.012","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}